QLT Inc. reported unaudited consolidated capital expenditure for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported cash provided by operating activities of $56,780,000 and expenditure on purchase of equipment was $469,000 compared to cash used in operating activities of $14,264,000 and expenditure on purchase of equipment of $199,000 for the same period previous year. For the nine months, the company reported cash provided by operating activities of $77,434,000 and expenditure on purchase of equipment was $492,000 compared to cash used in operating activities of $19,588,000 and expenditure on purchase of equipment of $374,000 for the same period previous year.

QLT Inc. provided sales guidance for the year 2009. The company expects some potential increase in sales as it move through 2010. For the third quarter 2009, capital expenditures were less than $0.5 million.

QLT Inc. reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported operating loss of $5,981,000, income from continuing operations before income taxes of $3,380,000, income from continuing operations was $2,236,000 or $0.04 diluted per share, net income of $8,921,000 or $0.16 diluted per share on net product revenue of $8,785,000 as compared to operating income of $17,046,000, income from continuing operations before income taxes of $15,886,000, income from continuing operations was $12,137,000 or $0.16 diluted per share, net income of $146,926,000 or $1.97 diluted per share on net product revenue of $8,785,000 for the same period last year. Accroding to non GAAP, the company reported operating loss of $4.6 million, loss from continuing operations before tax of $4.9 million, loss from continuing operations of $4.4 million or $0.08 per diluted share and net loss of $4.4 million or $0.08 per diluted share. For the nine months, the company reported operating loss of $15,934,000, income from continuing operations before income taxes of $344,000, income from continuing operations was $128,000, net income of $18,852,000 or $0.33 diluted per share on net product revenue of $8,785,000 as compared to operating loss of $4,349,000, income from continuing operations before income taxes of $7,141,000, income from continuing operations was $7,285,000 or $0.10 diluted per share, net income of $129,017,000 or $1.73 diluted per share on net product revenue of $36,462,000 for the same period last year. Accroding to non GAAP, the company reported operating loss of $8.6 million, loss from continuing operations before tax of $11.0 million, loss from continuing operations of $9.5 million or $0.17 per diluted share and net loss of $9.5 million or $0.17 per diluted share. The company revised earnigns guidance for the fourth quarter of 2009. In the fourth quarter the company expect to record a gain of over $100 million within income from discontinued operations related to the accounting gain on the sale, which represents the excess of the estimated present value of all consideration expected to be received under the deal compared to the net book value of the net assets that were sold. Guidance for Eligard sales was increased in its last earnings update to $240-255 million. Given that we will no longer be reporting any revenue from Eligard sales from statements of operations, the company is discontinuing its guidance for end-user Eligard sales. Guidance for adjusted EBITDA was increased in its last earnings call to $15-20 million.